Progressive encephalopathy with amyotrophy and optic atrophy was first linked to biallelic variants of TBCE in 2016 (PMID:27666369). Six probands from 4 unrelated Southern Italian families were described as having early onset slowly progressive distal motor neuropathy resembling spinal muscular atrophy with bilateral foot drop, spasticity, cerebellar ataxia and moderate to severe intellectual developmental disorder. Brain MRIs of these patients showed cerebellar atrophy; abnormal iron deposits were also recorded in the older patients. Other reports about a recurrent non-frameshift deletion responsible for the autosomal recessive Kenny-Caffey and Sanjad-Sakati syndromes are not included as they will be lumped in another curation. TBCE is required for the folding of a-tubulin, a/b-tubulin dimerization, and subsequent heterodimer polymerization into microtubules, which are major components of the cytoskeleton. Structurally contains a CAP-Gly domain which mediates protein binding to a-tubulin, nine tandemly arranged leucine-rich repeat (LRR) motifs which mediate protein-protein interaction, and a ubiquitin-like domain (UBL) which is implicated in a-tubulin degradation via the proteasome. The mechanism of pathogenicity is thus far associated with two recurrent variants; the homozygous p.Ile155Asn variant or the compound heterozygous c.924del:p.Leu309Ter variant. The gene-disease relationship is also supported by experimental evidence and specifically the mouse model pmn (PMID: 12446740), which is homozygous for the missense variant TBCE:p.Trp524Gly, and shares the same phenotypic features as those observed in affected individuals. In summary, TBCE is associated with autosomal recessive progressive encephalopathy with amyotrophy and optic atrophy, seen in 6 individuals. This was approved by the ClinGen Brain Malformation GCEP on 02/25/2025.
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.